- Recommendation ID
- IPG520/1
- Question
NICE encourages further research into radiofrequency ablation for gastric antral vascular ectasia and collaborative publication of data from local audit. Patient selection should be clearly documented, including details of prior treatments. Outcomes should include success and duration of effect in controlling bleeding and the effect of this on the need for blood transfusion. All complications should be reported. NICE may update the guidance on publication of further evidence.
- Any explanatory notes
(if applicable) Current evidence on radiofrequency ablation for gastric antral vascular ectasia raises no major safety concerns; however, evidence on its efficacy is inadequate in quantity. Therefore, this procedure should only be used with special arrangements for clinical governance, consent and audit or research.
Source guidance details
- Comes from guidance
- Radiofrequency ablation for gastric antral vascular ectasia
- Number
- IPG520
- Date issued
- June 2015
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |